In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: AdaptHealth Corp. appears significantly undervalued, with a current price at $10.80 versus a PERT fair value of $37.58 and a Monte Carlo median of $36.94. Strong growth (5/5) contrasts with weak profitability and efficiency (0/5), raising execution risk despite upside potential. High valuation volatility (101.67% coefficient of variation) signals substantial uncertainty.